PHIBRO ANIMAL HEALTH CORP (PAHC) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, PHIBRO ANIMAL HEALTH CORP's filing signal turned positive.

Phibro Animal Health Corporation is a global diversified company focused on animal health and mineral nutrition, providing solutions to livestock producers and veterinarians. The company markets approximately 800 product lines in about 90 countries to roughly 4,500 customers, covering poultry, swine, beef and dairy cattle, and aquaculture. Its product portfolio includes medicated feed additives (MFAs), nutritional specialties, and vaccines, designed to prevent, control, and treat diseases and support animal nutrition. Phibro also manufactures specialty ingredients for the personal care, industrial chemical, and chemical catalyst industries. The company recently expanded its offerings through the acquisition of Zoetis's medicated feed additive portfolio, which contributed significantly to its fiscal year 2025 net sales.

Revenue is primarily driven by the sale of animal health products, including medicated feed additives, nutritional specialties, and vaccines, as well as mineral nutrition products for livestock. The recent acquisition of Zoetis's MFA portfolio significantly boosted Animal Health segment sales.